PTGX
Protagonist Therapeutics, Inc.When PTGX passed all Ten ChecksProtagonist Therapeutics, Inc.
history · not a forecastOver the past 10 years, PTGX has passed all Ten Checks on 7 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +47.8% in Sep 2025, still rising at session 20.
- Sep 2025+47.8% -0.8%
- Feb 2024+16.1% +2.4%
- Jan 2024+23.9% +4.1%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about PTGX’s checks
How many technical checks does PTGX pass right now?
As of the Aug 26, 2026 close, PTGX passes 7 of 10 fixed technical checks — the checks not passing: market trend rising, holding above short-term average, adequate stop room.
Why does PTGX fail the "holding above short-term average" check?
PTGX closed at $151.50, 0.5% below its 9-day average ($152.21), so this momentum check fails. It passes again on a close above $152.21.
What price would change PTGX's check count?
The nearest flip level is "stop distance within range" fails on a close outside $150.69 – $160.52. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.